Crosstalk between Ca(2+) Signaling and Cancer Stemness: The Link to Cisplatin Resistance

In the fight against cancer, therapeutic strategies using cisplatin are severely limited by the appearance of a resistant phenotype. While cisplatin is usually efficient at the beginning of the treatment, several patients endure resistance to this agent and face relapse. One of the reasons for this...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouba, Sana, Hague, Frédéric, Ahidouch, Ahmed, Ouadid-Ahidouch, Halima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503744/
https://www.ncbi.nlm.nih.gov/pubmed/36142596
http://dx.doi.org/10.3390/ijms231810687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503744/
https://www.ncbi.nlm.nih.gov/pubmed/36142596
http://dx.doi.org/10.3390/ijms231810687

Ejemplares similares